Sanofi - Common Stock and American Depositary Receipts (SNY)

Historical Holders from Q1 2014 to Q3 2025

Symbol
SNY on Nasdaq
CUSIP
80105N105
Type / Class
Equity / Common Stock and American Depositary Receipts
Shares outstanding
1.23B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
237M
Holdings value
$11.2B
% of all portfolios
0.013%
Grand Portfolio weight change
-0.001%
Number of holders
688
Number of buys
312
Number of sells
-337
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sanofi - Common Stock and American Depositary Receipts (SNY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Amundi 5.21% +3.6% $3.02B $100M 63.9M +3.45% AMUNDI Sep 30, 2025

Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 237M $11.2B -$540M $47.20 688
2025 Q2 245M $11.8B -$578M $48.31 717
2025 Q1 260M $14.4B -$180M $55.46 755
2024 Q4 264M $12.8B -$861M $48.23 709
2024 Q3 281M $16.2B +$600M $57.63 739
2024 Q2 271M $13.2B +$735M $48.52 708
2024 Q1 256M $12.5B +$385M $48.60 694
2023 Q4 160K $7.95M -$4.96M $49.73 6
2023 Q3 251M $13.5B -$165M $53.64 675
2023 Q2 254M $13.7B -$854M $53.90 654
2023 Q1 257M $14B +$261M $54.42 652
2022 Q4 260M $12.6B +$348M $48.43 617
2022 Q3 242M $9.2B +$23M $38.02 552
2022 Q2 258M $12.9B +$534M $50.03 627
2022 Q1 251M $12.9B +$356M $51.34 601
2021 Q4 244M $12.2B +$344M $50.10 602
2021 Q3 236M $11.4B +$1.64B $48.21 567
2021 Q2 202M $10.6B +$297M $52.66 571
2021 Q1 197M $9.72B +$1.14B $49.46 559
2020 Q4 175M $8.48B +$63.8M $48.59 586
2020 Q3 173M $8.67B -$299M $50.17 559
2020 Q2 179M $9.12B -$307M $51.05 567
2020 Q1 181M $7.92B +$321M $43.72 529
2019 Q4 179M $8.99B +$33M $50.20 511
2019 Q3 178M $8.26B +$171M $46.33 470
2019 Q2 175M $7.55B -$261M $43.27 466
2019 Q1 181M $8.02B +$106M $44.28 478
2018 Q4 179M $7.75B +$60.3M $43.41 491
2018 Q3 175M $7.82B -$494M $44.67 468
2018 Q2 189M $7.55B -$950M $40.01 467
2018 Q1 213M $8.52B -$562M $40.08 478
2017 Q4 225M $9.69B -$178M $43.00 491
2017 Q3 229M $11.4B -$309M $49.79 474
2017 Q2 235M $11.3B -$696M $47.91 468
2017 Q1 250M $11.3B +$48.5M $45.25 449
2016 Q4 250M $10.1B -$114M $40.44 468
2016 Q3 253M $9.65B +$367M $38.19 441
2016 Q2 242M $10.1B +$420M $41.85 443
2016 Q1 231M $9.32B +$92.6M $40.16 437
2015 Q4 228M $9.72B -$547M $42.65 471
2015 Q3 221M $10.5B -$443M $47.47 485
2015 Q2 250M $12.4B -$238M $49.53 489
2015 Q1 256M $12.7B +$433M $49.44 507
2014 Q4 249M $11.4B +$335M $45.61 490
2014 Q3 241M $13.6B +$166M $56.43 494
2014 Q2 238M $12.6B +$125M $53.17 482
2014 Q1 236M $12.3B +$595M $52.28 482